These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 19444726)

  • 21. Adverse drug-related effects among electronic dance music party attendees.
    Palamar JJ; Acosta P; Le A; Cleland CM; Nelson LS
    Int J Drug Policy; 2019 Nov; 73():81-87. PubMed ID: 31349134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concurrent use of methamphetamine, MDMA, LSD, ketamine, GHB, and flunitrazepam among American youths.
    Wu LT; Schlenger WE; Galvin DM
    Drug Alcohol Depend; 2006 Sep; 84(1):102-13. PubMed ID: 16483730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of perceived parenting style on the propensity for illicit drug use: the importance of parental warmth and control.
    Montgomery C; Fisk JE; Craig L
    Drug Alcohol Rev; 2008 Nov; 27(6):640-9. PubMed ID: 18821098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Illicit drug use among New Zealand gay and bisexual men: Prevalence and association with sexual health behaviours.
    Saxton P; Newcombe D; Ahmed A; Dickson N; Hughes A
    Drug Alcohol Rev; 2018 Feb; 37(2):180-187. PubMed ID: 28439922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The problem of "just for fun": patterns of use situations among active club drug users.
    Starks TJ; Golub SA; Kelly BC; Parsons JT
    Addict Behav; 2010 Dec; 35(12):1067-73. PubMed ID: 20696530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attributions for psychobiological changes in ecstasy/MDMA and other polydrug users.
    Soar K; Parrott A; Turner J
    J Psychopharmacol; 2009 Sep; 23(7):745-58. PubMed ID: 18635698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Profiles of club drug users in treatment.
    Maxwell JC; Spence RT
    Subst Use Misuse; 2005; 40(9-10):1409-26. PubMed ID: 16048825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circumstances of initiation into new-type drug use among adults in Shanghai: are there differences by types of first new-type drug used?
    Ding Y; He N; Detels R
    Drug Alcohol Depend; 2013 Aug; 131(3):278-83. PubMed ID: 23312339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Motivations for Selling Ecstasy among Young Adults in the Electronic Dance Music Club Culture in Brazil.
    Remy LS; Buttram ME; Kurtz SP; Surratt HL; Pechansky F
    J Psychoactive Drugs; 2017; 49(5):420-426. PubMed ID: 28692339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dinosaur girls, candy girls, and Trinity: voices of Taiwanese club drug users.
    Leung KS; Li JH; Tsay WI; Callahan C; Liu SF; Hsu J; Hoffer L; Cottler LB
    J Ethn Subst Abuse; 2008; 7(3):237-57. PubMed ID: 19042808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential Risk for Drug Use by Sexual Minority Status among Electronic Dance Music Party Attendees in New York City.
    Griffin M; Callander D; Duncan DT; Palamar JJ
    Subst Use Misuse; 2020; 55(2):230-240. PubMed ID: 31530057
    [No Abstract]   [Full Text] [Related]  

  • 32. Club drugs: MDMA, gamma-hydroxybutyrate (GHB), Rohypnol, and ketamine.
    Gahlinger PM
    Am Fam Physician; 2004 Jun; 69(11):2619-26. PubMed ID: 15202696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trends in drug use among electronic dance music party attendees in New York City, 2016-2019.
    Palamar JJ; Keyes KM
    Drug Alcohol Depend; 2020 Apr; 209():107889. PubMed ID: 32050110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Consistency and change in club drug use by sexual minority men in New York City, 2002 to 2007.
    Pantalone DW; Bimbi DS; Holder CA; Golub SA; Parsons JT
    Am J Public Health; 2010 Oct; 100(10):1892-5. PubMed ID: 20724693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship between club drug use and other drug use: a survey of New York City middle school students.
    Goldsamt LA; O'Brien J; Clatts MC; McGuire LS
    Subst Use Misuse; 2005; 40(9-10):1539-55. PubMed ID: 16048832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems.
    Parrott AC; Milani RM; Parmar R; Turner JD
    Psychopharmacology (Berl); 2001 Dec; 159(1):77-82. PubMed ID: 11797073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of perceived quality on the behavioural economics of alcohol, amphetamine, cannabis, cocaine, and ecstasy purchases.
    Cole JC; Goudie AJ; Field M; Loverseed AC; Charlton S; Sumnall HR
    Drug Alcohol Depend; 2008 Apr; 94(1-3):183-90. PubMed ID: 18201842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Past 12-month and lifetime comorbidity and poly-drug use of ecstasy users among young adults in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
    Keyes KM; Martins SS; Hasin DS
    Drug Alcohol Depend; 2008 Sep; 97(1-2):139-49. PubMed ID: 18524499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ecstasy (MDMA) and high prevalence psychiatric symptomatology: somatic anxiety symptoms are associated with polydrug, not ecstasy, use.
    Bedi G; Van Dam NT; Redman J
    J Psychopharmacol; 2010 Feb; 24(2):233-40. PubMed ID: 18832429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Self-reports of executive dysfunction in current ecstasy/polydrug Users.
    Hadjiefthyvoulou F; Fisk JE; Montgomery C; Bridges N
    Cogn Behav Neurol; 2012 Sep; 25(3):128-38. PubMed ID: 22960437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.